<DOC>
	<DOCNO>NCT02333253</DOCNO>
	<brief_summary>40 patient attend IVF center 2013 &amp; 2014 fulfilling criterion poor response fail go OPU give &lt; 3 mature follicle dose 300U GN . All patient revise history , examination investigation , include age , type duration infertility , day 3 FSH , Day 3 E2 , AMH , AFC .</brief_summary>
	<brief_title>Delayed Start Versus Conventional Antagonist Protocol Poor Responders Pretreated Estradiol Luteal Phase</brief_title>
	<detailed_description>40 patient attend IVF center 2013 &amp; 2014 fulfilling criterion poor response fail go OPU give &lt; 3 mature follicle dose 300U GN . All patient revise history , examination investigation , include age , type duration infertility , day 3 FSH , Day 3 E2 , AMH , AFC All patient 35 year old ore We exclude patient &gt; 44ys , AMH &lt; 0.3ng/ml , FSH &gt; 13 , also patient DM , endometriosis , general disease exclude , local uterine anomaly exclude . All patient receive OCP one cycle Then take estradiol tablet 2 mg one week prior menses test cycle Day 21 day 28 Then divide 2 group US do exclude cyst follicle &gt; 10mm First group receive 300 U r FSH +150 U urinary GN day 2 till day HCG , dose adjust accord response 0.25 cetrotide S.c add lead follicle reach &gt; 12 mm , HCG give least 3 mature follicle &gt; 14 mm lead one &gt; 17mm OPU do 36 hr HCG , oocytes denuded fertilize ICSI avoid low fertilization rate conventional IVF , embryo transfer do day 3 least one embryo GI wise cancel ET , cyclogest 800mg give intravaginal 14 day quantitative BHCG do consider positive &gt; 5miu/ML 28 day ET , TVS do confirm ongoing pregnancy visualization IU sac . Second group receive cetrotide 0.25 mg s.c alone day 2 day 8then initiate GN therapy initial GN dose ( 300FSH+150U urinary GN ) .same adjustment dose do antagonist restart DF &gt; 12mm , till day HCG , HCG , OPU , ET do method criterion , luteal support follow .</detailed_description>
	<mesh_term>Cetrorelix</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>1 Poor responder 2 . Age &gt; 35 year 1. patient &gt; 44ys , 2 . AMH &lt; 0.3ng/ml , 3 . FSH &gt; 13 , also 4. patient DM , endometriosis , general disease exclude , 5. local uterine anomaly exclude .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>poor responder</keyword>
	<keyword>GnRH antagonist</keyword>
	<keyword>Conventional protocol</keyword>
</DOC>